U.P. 2026 is the inaugural Universal Project of the Givingtide framework — and this is what it will build: the world's first medical institution devoted entirely to prevention, integrating research, clinical care, policy innovation, and global training to permanently transform how humanity relates to disease.
IoP modelling projects an avoidance of 60 million premature deaths within the first decade of full operation — through prevention protocols, trained practitioners, and health systems embedded across the global network.
Estimated economic productivity restored by 2035 — representing working years recovered, treatment costs avoided, and human capital returned to productive life across the IoP's operating regions.
The inaugural target of the IoP Medical School: 10,000 qualified Preemptologists seeded across every continent, anchored in high-burden settings, and equipped to lead prevention-first health systems.
The Global Challenge
The architecture of global health has been built around a single premise: that medicine begins when symptoms appear. For most of human history, this was unavoidable. Today, it is unconscionable.
Every year, the world watches as preventable diseases advance unchallenged through populations that lack the clinical infrastructure, trained personnel, or institutional frameworks to intercept illness before it becomes crisis. The result is not merely a health failure — it is a systemic economic, social, and civilisational collapse playing out in slow motion.
Most health systems are designed to manage disease after it has already taken hold: to treat what could have been prevented, to rehabilitate what could have been protected, and to mourn what could have been saved. The case for redesigning those systems around prevention is not radical — it is rational. What has been missing is not the argument. It is the institution.
The Institute of Preemptology is that institution.
Prevention is not the absence of cure. It is the presence of foresight — and the institutional courage to act before the damage is done.
Eight million people die each year from conditions that could have been detected, intercepted, or eliminated had prevention been the system's primary orientation.
Nearly five million children under the age of five die each year — the overwhelming majority from diseases preventable through early intervention, nutrition, immunisation, and environmental health.
Medical expenditure drives 344 million people into extreme poverty annually — not because health systems lack capacity to treat, but because they never invested in preventing the disease in the first place.
The Solution
Preemptology is the world's first medical specialty dedicated entirely and systematically to prevention. It is not a rebranding of public health, a refinement of primary care, or an extension of wellness medicine. It is a new clinical and scientific discipline — purpose-built to do what no existing specialty has been structured to achieve: to detect risk, model disease trajectories, and intervene at the earliest possible biological, behavioural, and environmental moment.
As an integrated discipline, Preemptology spans the full arc of health science — drawing from medicine, public health, epidemiology, genomics, health policy, and emerging technology. It positions prevention not as a preventative footnote within an existing specialty, but as the organising logic of a complete field of practice and inquiry.
The goal is a health system that does not merely respond to disease, but anticipates, intercepts, and dismantles the conditions from which disease emerges — reaching from the molecular scale to the biosphere. This is the discipline's founding ambition, captured in its governing phrase:
Prevention-first clinical practice across primary and specialist care — screening, risk stratification, and early intervention protocols.
Population-level surveillance, epidemiological modelling, and the design of preventive health systems at community and national scale.
Institutional policy frameworks that embed prevention within national health strategies, global health financing, and multilateral agreements.
Laboratory-to-clinic translation of preventive insights — genomics, biomarker science, and environmental health research applied to pre-disease intervention.
AI-driven risk modelling, wearable biosurveillance, digital therapeutics, and precision prevention platforms at population scale.
From bench to bed to biosphere — Preemptology pursues prevention at every scale, from the cellular to the civilisational.
The Institution
The IoP will be the world's first dedicated institution for prevention medicine — a permanent, globally oriented complex combining research excellence, clinical translation, medical education, and policy leadership under a single institutional mandate.
Foundational and applied research into prevention science — from molecular biomarkers of early disease to population-level risk modelling. The IoP Research Centre will generate the evidence base for a new preventive medicine paradigm.
A dedicated clinical infrastructure designed to translate research findings into prevention protocols, screening programmes, and frontline care pathways — closing the gap between laboratory insight and patient benefit.
The IoP Medical School will design and deliver the curriculum for the world's first Preemptology training programme — producing practitioners equipped to lead prevention-centred health systems globally.
An embedded policy unit generating the institutional frameworks, health financing models, and multilateral advocacy needed to integrate Preemptology into national health strategies and international agreements.
A fellowship and exchange network linking the IoP to health institutions across six continents — training the next generation of Preemptologists in every region where preventable disease remains the dominant burden.
The overarching goal of the Institute is to establish prevention as a core pillar of global health infrastructure — as foundational as treatment, as credentialed as surgery, and as globally distributed as primary care.
Capital Structure
Four interconnected pillars of capitalisation, progressing from institutional foundation to permanent global endowment. Together they constitute a self-sustaining prevention ecosystem designed to outlast every generation it serves.
The anchor institution. Establishes the research centre, clinical facilities, and operational headquarters in Enugu — the physical and intellectual home of Preemptology as a global discipline.
The training engine of the new discipline. Funds the world's first Preemptology school — faculty recruitment, curriculum development, campus construction, and the inaugural 10,000-student training programme.
A world-class cancer prevention and treatment complex — anchoring the clinical dimension of Preemptology with a flagship demonstration that prevention-first oncology achieves superior patient outcomes at lower system cost.
The financial foundation of permanence. A sovereign-scale endowment ensuring the IoP and its affiliated institutions operate without dependence on political cycles, donor discretion, or economic volatility — in perpetuity.
Together, these four pillars create a self-sustaining prevention ecosystem: an institution that generates its own research, trains its own practitioners, demonstrates its own clinical efficacy, and funds its own continuity — indefinitely and at global scale.
Strategic Location
The flagship IoP complex will be established in Enugu, Nigeria — a deliberate, strategic choice that places the world's first prevention institute at the intersection of greatest need and greatest opportunity. Sub-Saharan Africa bears a disproportionate burden of preventable disease, and it is precisely here that prevention systems can deliver the most measurable returns.
Enugu offers more than a humanitarian mandate. It offers the real-world testing conditions that no wealthy-nation campus can replicate: high disease burden, resource-constrained health systems, a young and rapidly growing population, and the scale of unmet preventive need that will stress-test, sharpen, and ultimately validate every protocol the Institute develops.
Prevention science proven in Enugu is prevention science that works everywhere. That is the logic of the location — and the source of its global credibility.
Primary research, clinical, and medical education complex. The institutional home of the Institute of Preemptology and the site of its inaugural prevention systems work.
International engagement, donor relations, global partnerships, and North American institutional liaison. Positioned to serve as the IoP's bridge to multilateral and Western health institutions.
Real-world testing at scale. Enugu provides the clinical complexity, epidemiological diversity, and health system conditions needed to develop prevention protocols that generalise globally — not merely within wealthy-nation contexts.
Equity-centred innovation. A prevention institute grounded in the Global South ensures that the discipline of Preemptology is built for the populations who need it most — not retrofitted to them after the fact.
Continental health leadership. Nigeria's population, institutional networks, and growing health research capacity position Enugu as a natural continental hub for African health innovation.
Global relevance, proven locally. Prevention science that succeeds in Enugu carries a credibility that no high-income-country institution alone can claim — grounding the IoP's global authority in demonstrated, equitable impact.
Projected Global Impact
The projections below are grounded in IoP modelling and established global health evidence. They represent the consequence of establishing the world's first prevention-centred medical institution at the scale the IoP envisions — and of operating it for a decade.
Sixty million preventable deaths avoided through prevention protocols, trained practitioners, and embedded health systems operating across the IoP's global network.
Mortality ReductionThrough the Comprehensive Cancer Centre's prevention programme and the IoP's vaccination and screening infrastructure, cervical cancer — among the most preventable of all cancers — reaches elimination as a public-health threat.
Disease EliminationAn estimated $1.6 trillion in economic productivity restored — representing the working years saved, the healthcare expenditure avoided, and the human capital returned to productive life.
Economic ImpactTen thousand trained Preemptologists distributed across every region, anchored in high-burden settings, and seeding prevention-first practice within health systems that have never had access to it before.
Workforce DevelopmentStrategic Rationale
The Universal Project framework selects its inaugural project with rigour. The Institute of Preemptology was chosen because it satisfies every dimension of the nine U.P. criteria — and because the case for prevention as global health's most powerful lever is, at this moment in history, irrefutable.
No intervention in the health sciences produces returns comparable to prevention. Every dollar invested in pre-disease intervention averts multiples in treatment cost, lost productivity, and human suffering. The IoP institutionalises this logic permanently.
Unlike interventions designed for specific diseases or populations, Preemptology as a discipline scales across every condition, every continent, and every health system. Its benefits compound over time rather than plateauing.
Deaths prevented, diseases eliminated, practitioners trained, and productivity restored are all quantifiable outcomes. The IoP's impact is not a matter of faith — it is a matter of measurement. Funders can track what their investment achieves.
The Institute of Preemptology will not be complete in a decade. It is designed to outlast its founders, outlast its current funders, and endow the world with a permanent prevention infrastructure that operates across centuries. That is the ambition the inaugural Universal Project demands.
The Founding Circle
Founding partners are not donors. They are architects. Their names will be inscribed in the institutional record of a discipline that will endure for generations.
Founding Circle partners will help establish the first global discipline of prevention medicine, shape the curriculum and research agenda of the IoP Medical School, and constitute the institutional base from which a permanent prevention infrastructure is built — one that will train practitioners, generate knowledge, and protect lives long after this founding moment has passed into history.
Ultra-high-net-worth individuals and family offices committed to the capitalisation of the Institute's founding infrastructure and endowment. Named fellowships, professorial chairs, and research programmes carry the founder's legacy permanently within the institution.
Major global foundations whose mission intersects with prevention, global health equity, or the transformation of health systems. Programme-linked and endowment-linked structures ensure alignment between the foundation's mandate and the IoP's research and education priorities.
World-leading universities and research institutions invited to co-create the IoP's curriculum, co-author its founding research agenda, and establish joint appointments that seed the global Preemptology faculty with the world's finest academic minds.
National governments and ministries of health committing bilateral support to the IoP's launch. Government partners shape the policy frameworks that will eventually embed Preemptology within national health strategies — transforming a new discipline into a global standard of care.
Technology companies and innovation funds with AI, digital health, or precision medicine capabilities that can accelerate the Institute's early detection, risk modelling, and biosurveillance programmes. Technology partners co-design the platforms that will make Preemptology scalable at population level.
Multilateral institutions, sovereign wealth funds, and international health bodies whose endorsement and co-investment will anchor the IoP within the architecture of global health governance from its founding day — conferring the institutional credibility that no single nation or donor can provide alone.
The Invitation
Founding partners have the opportunity to shape the first global institute of prevention medicine, participate in a historic philanthropic collaboration, and establish a legacy that endures long after any single generation.